Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

× No keyword cloud information.

15 in total

Review 1. [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Authors: R W C Janzen; W D Ludwig
Journal: Z Rheumatol Date: 2012-02 Impact factor: 1.372

2. Ten common questions (and their answers) about off-label drug use.

Authors: Christopher M Wittich; Christopher M Burkle; William L Lanier
Journal: Mayo Clin Proc Date: 2012-08-06 Impact factor: 7.616

3. Off-label drug information: regulation, distribution, evaluation, and related controversies.

Authors: C Lee Ventola
Journal: P T Date: 2009-08

4. Covert pharmaceutical promotion in free medical journals.

Authors: Aaron S Kesselheim
Journal: CMAJ Date: 2011-02-28 Impact factor: 8.262

Review 5. Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors: Jacob T Borodovsky; Alan J Budney
Journal: Int Rev Psychiatry Date: 2018-05-29

6. Off-label, but on-target: use of regadenoson with exercise.

Authors: Robert C Hendel; Lauren Frost
Journal: J Nucl Cardiol Date: 2013-04 Impact factor: 5.952

7. Unhealthy marketing of pharmaceutical products: An international public health concern.

Authors: Shai Mulinari
Journal: J Public Health Policy Date: 2016-02-25 Impact factor: 2.222

8. Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.

Authors: Aaron S Kesselheim; Michelle M Mello; David M Studdert
Journal: PLoS Med Date: 2011-04-05 Impact factor: 11.069

9. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease.

Authors: Giovanni Tafuri; Francesco Trotta; Hubert G M Leufkens; Nello Martini; Luciano Sagliocca; Giuseppe Traversa
Journal: Eur J Clin Pharmacol Date: 2008-09-17 Impact factor: 2.953

10. Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation.

Authors: S Swaroop Vedula; Palko S Goldman; Ilyas J Rona; Thomas M Greene; Kay Dickersin
Journal: Trials Date: 2012-08-13 Impact factor: 2.279